Since 2014, Pfizer has used artificial intelligence to help sort through and categorize reports that people file when they experience an “adverse event.”

Pfizer is providing participants with their own clinical trial data when an eligible trial ends via the Clinical Trial Participant Data Return Initiative.

Scientists across disciplines use mathematical models to make predictions and understand complicated real-world systems, like the weather or financial markets or biology.

One billion people worldwide live with migraine; that’s about one in seven. So it's likely someone you work with experiences migraine in the workplace.

For Pfizer's Biopharma Global Chief Marketing Officer Drew Panayiotou, working at Pfizer comes with an enormous perk. The potential to change the world.